LAVA Therapeutics Statistics Share Statistics LAVA Therapeutics has 26.31M
shares outstanding. The number of shares has increased by 0.05%
in one year.
Shares Outstanding 26.31M Shares Change (YoY) 0.05% Shares Change (QoQ) 0.05% Owned by Institutions (%) 25.64% Shares Floating 13.02M Failed to Deliver (FTD) Shares 400 FTD / Avg. Volume 0.59%
Short Selling Information The latest short interest is 51.71K, so 0.2% of the outstanding
shares have been sold short.
Short Interest 51.71K Short % of Shares Out 0.2% Short % of Float 0.32% Short Ratio (days to cover) 1.81
Valuation Ratios The PE ratio is -1.02 and the forward
PE ratio is -2.15.
LAVA Therapeutics's PEG ratio is
0.03.
PE Ratio -1.02 Forward PE -2.15 PS Ratio 2.13 Forward PS 1.7 PB Ratio 0.92 P/FCF Ratio -1.3 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for LAVA Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.4,
with a Debt / Equity ratio of 0.19.
Current Ratio 4.4 Quick Ratio 4.4 Debt / Equity 0.19 Debt / EBITDA -0.22 Debt / FCF -0.27 Interest Coverage -57.66
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $352.41K Profits Per Employee $-738.65K Employee Count 34 Asset Turnover 0.15 Inventory Turnover n/a
Taxes Income Tax 630K Effective Tax Rate -2.57%
Stock Price Statistics The stock price has increased by -16.02% in the
last 52 weeks. The beta is 0.49, so LAVA Therapeutics's
price volatility has been higher than the market average.
Beta 0.49 52-Week Price Change -16.02% 50-Day Moving Average 1.38 200-Day Moving Average 1.32 Relative Strength Index (RSI) 60.06 Average Volume (20 Days) 67,933
Income Statement In the last 12 months, LAVA Therapeutics had revenue of 11.98M
and earned -25.11M
in profits. Earnings per share was -0.94.
Revenue 11.98M Gross Profit 11.52M Operating Income -29.69M Net Income -25.11M EBITDA -23.5M EBIT -23.97M Earnings Per Share (EPS) -0.94
Full Income Statement Balance Sheet The company has 35.02M in cash and 5.28M in
debt, giving a net cash position of 29.73M.
Cash & Cash Equivalents 35.02M Total Debt 5.28M Net Cash 29.73M Retained Earnings -174.97M Total Assets 71.16M Working Capital 59.41M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -19.54M
and capital expenditures -23K, giving a free cash flow of -19.57M.
Operating Cash Flow -19.54M Capital Expenditures -23K Free Cash Flow -19.57M FCF Per Share -0.73
Full Cash Flow Statement Margins Gross margin is 96.1%, with operating and profit margins of -247.81% and -209.6%.
Gross Margin 96.1% Operating Margin -247.81% Pretax Margin -204.34% Profit Margin -209.6% EBITDA Margin -196.14% EBIT Margin -247.81% FCF Margin -163.3%
